Navigation Links
Female hormone cycle affects knee joints
Date:4/17/2009

New research from the Faculty of Kinesiology at the University of Calgary has found a connection between the laxity of a woman's knee joint and her monthly hormone cycle.

The research project a collaboration between kinesiology, engineering and health sciences researchers has found that not all woman experience knee laxity at the same time of their menst rual cycle. The researchers speculate that this is likely why previous research in the area has largely discounted a connection between the hormone cycle and knee injury.

In a series of recent papers published in the British Journal of Sports Medicine and The American Journal of Sports Medicine the researchers noted that while 14 of 26 subjects exhibited the greatest amount of knee laxity during the ovulation phase, while 10 others had the greatest laxity during the follicular phase and 2 subjects during the luteal phase.

"What this shows us is that the connection between the hormonal cycle and knee laxity is not a cookie-cutter relationship," says one of the studies' lead authors, Faculty of Kinesiology professor Darren Stefanyshyn. "Individuals have significant differences and I think that finding out why these differences occur could go a long way to helping athletes understand if they are more at risk and perhaps in designing interventions to help prevent injury."

In the University of Calgary study, 26 women were monitored throughout the course of their monthly course of cycle. Their knee laxity was measured at each phase and they were asked to perform several athletic movements like quick cuts, or sharp jumps. The researchers found that the greater knee laxity lead to biomechanical differences that could lead to injury in a game situation.

Female athletes are between two and eight times more likely to injure their ACL knee ligaments than men. ACL injuries remain one of the biggest concerns in orthopaedic sports medicine and it is estimated that these injuries cost the health care system nearly $2 billion annually.

Young athletes who suffer knee injuries are far more likely to suffer knee osteoarthritis when they age, and are at risk for a much less active life-style following injury.

e 14 of 26 subjects exhibited the greatest amount of knee laxity during the ovulation phase, while 10 others had the greatest laxity during the follicular phase and 2 subjects during the luteal phase.

"What this shows us is that the connection between the hormonal cycle and knee laxity is not a cookie-cutter relationship," says one of the studies' lead authors, Faculty of Kinesiology professor Darren Stefanyshyn. "Individuals have significant differences and I think that finding out why these differences occur could go a long way to helping athletes understand if they are more at risk and perhaps in designing interventions to help prevent injury."

In the University of Calgary study, 26 women were monitored throughout the course of their monthly course of cycle. Their knee laxity was measured at each phase and they were asked to perform several athletic movements like quick cuts, or sharp jumps. The researchers found that the greater knee laxity lead to biomechanical differences that could lead to injury in a game situation.

Female athletes are between two and eight times more likely to injure their ACL knee ligaments than men. ACL injuries remain one of the biggest concerns in orthopaedic sports medicine and it is estimated that these injuries cost the health care system nearly $2 billion annually.

Young athletes who suffer knee injuries are far more likely to suffer knee osteoarthritis when they age, and are at risk for a much less active life-style following injury.


'/>"/>

Contact: Don McSwiney
don.mcswiney@ucalgary.ca
403-220-7652
University of Calgary
Source:Eurekalert

Related medicine news :

1. Male Cosmetic Surgery Slows Down While Female Cosmetic Surgery Advances
2. Female Entrepreneurs Secure $4M in New Financing for UpSpring Baby
3. Hormone Might Help Restore Female Fertility
4. Studying the female form
5. The Female Health Company to Expand Manufacturing Capacity for FC2 Female Condom By 150%
6. U.S. Food and Drug Administration Approves New Female Condom
7. The Female Health Company Schedules Conference Call to Discuss FDA Approval of FC2 Female Condom(R) for March 12, 2009
8. Female Health Company Receives FDA Approval for FC2 Female Condom(R)
9. Female genital mutilation among Israels Negev Bedouins has virtually disappeared -- BGU study
10. The Female Health Company Expands and Extends Its Stock Repurchase Program
11. The Female Health Company Reports First Quarter Operating Results, as Gross Profit Margins Widen on Increasing Sales of FC2 Female Condom(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... ... February 17, 2017 , ... For ... assistance management solution to the exhibit floor for the 2017 HIMSS Conference ... , From Feb. 19–23, 2017, more than 40,000 healthcare industry professionals are expected ...
(Date:2/17/2017)... Seattle, WA (PRWEB) , ... February 17, 2017 ... ... health management organizations, has been named a finalist in the 8th Annual DecisionHealth ... impacting America's healthcare delivery system. Qualis Health’s work is recognized across multiple award ...
(Date:2/17/2017)... ... 2017 , ... Pharmica Consulting attended CHI's 8th Annual SCOPE ... trial planning and management. Pharmica discussed the importance of effective project management, data ... by Pharmica’s booth were able to demo its cloud-based Resource Management Tool, ...
(Date:2/17/2017)... ... February 17, 2017 , ... Top neuroendocrine cancer doctors, nurses and specialists from ... February 21 - 23 in Beaver Creek, CO. It was announced today by Cindy ... year in Beaver Creek, hosting over 60 faculty members and addressing unmet needs of ...
(Date:2/16/2017)... ... 17, 2017 , ... For some cancer survivors, the memories ... Physician researchers at The Marcus Institute of Integrative Health at Thomas Jefferson ... reducing symptoms of traumatic stress in cancer patients and published their results ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... 17, 2017  Noble Capital Markets announced today that ... (Nasdaq: EPIX ). The report was issued ... , PhD. ESSA Pharmaceuticals is a clinical ... cancer (CRPC). Its lead compound EPI-506, is a small ... of the androgen receptor, thereby has potential to overcome ...
(Date:2/16/2017)... Quest Diagnostics (NYSE: DGX ), ... announced that it has been named one of the ... The annual survey designated Quest Diagnostics as ... Pharmacy and Other Services" industry to attain Most Admired ... attain the designation. This is the second consecutive year ...
(Date:2/16/2017)... Feb. 16, 2017  Aralez Pharmaceuticals Inc. (NASDAQ: ... company, today announced that executive management will participate in ... held February 22-23, 2017. Adrian Adams , Chief ... at 1:35 p.m. local time on Wednesday, February 22, ... for the event may be accessed from the Investors ...
Breaking Medicine Technology: